All EpiPen articles

Article

Mylan finalizes $30M EpiPen settlement with SEC

2019-09-30T14:28:00Z

Mylan has finalized a previously disclosed $30 million settlement with the SEC for alleged accounting and disclosure failures surrounding its popular EpiPen.

Article

Mylan nears $30M settlement with SEC in EpiPen investigation

2019-07-31T16:35:00Z

Mylan disclosed in a regulatory filing that it has reached a $30 million agreement-in-principle to resolve the SEC’s investigation alleging securities violations for disclosures surrounding EpiPens.